What People Buy Milk Thistle For
Milk thistle (Silybum marianum) and its main active compound silymarin have been the default "liver supplement" in North American pharmacies for at least 30 years. The pitch is simple: silymarin is an antioxidant flavonoid complex, it supports liver function, and it has been studied. Both halves of that statement are true. The hard part is what the studies actually found.
Silymarin's strongest evidence sits in metabolic and fatty liver disease, not alcohol. A 2024 systematic review of randomized trials in MASLD (formerly NAFLD) showed reductions in ALT, AST, and fatty liver index across thousands of patients1. That is a real signal. It is also a different condition than what most people are buying milk thistle for, which is recovery support after drinking.
The Alcohol Side of the Evidence
When you look at milk thistle in alcohol-related liver disease specifically, the picture gets thin. A Cochrane review of milk thistle for alcoholic and viral hepatitis liver disease found no significant effect on mortality, on liver biopsy histology, or on the biochemical markers of liver function in patients with alcohol-related disease2. The AHRQ evidence report (US government, NIH bookshelf) reached a similar conclusion -- the data are too limited to demonstrate a substantial benefit on outcomes that matter3.
The mechanism story explains why. Silymarin is primarily an antioxidant -- it scavenges reactive oxygen species and supports glutathione recycling. That is downstream protection, after the damage is already happening. It does not act on ADH or ALDH, the two enzymes that actually metabolize ethanol and acetaldehyde, so it has no direct effect on the rate of alcohol clearance.
Where DHM Sits Differently
Acts by promoting aldehyde and alcohol metabolism of foods.†
† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
DHM (dihydromyricetin) acts upstream, in animal studies at least. A 2020 study in mice reported that DHM raised the liver's ADH and ALDH and lowered ethanol and acetaldehyde levels after alcohol5. The 2012 paper by Shen and colleagues is often cited for this, but it studied injected DHM and alcohol intoxication in rats, not liver enzymes4. That is a different mechanism than silymarin's: one of them helps the liver clean up after damage, and the other may help it clear the source of damage faster, though that has been studied in rodents, not people.
Triggers the liver to produce more of the aldehyde- and alcohol-metabolizing enzymes (ADH and ALDH) and boosts their efficiency in breaking down aldehydes and alcohols in foods as well as their by-products.†
† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
DHM also moves liver enzyme markers (AST and ALT) in the right direction in animal studies of ethanol-induced damage, in the same direction silymarin does in MASLD studies but for a different underlying reason5. Both compounds help in their lane. They help in different lanes.
What This Means for the Stack
For someone whose main concern is alcohol metabolism specifically -- the speed of clearing ethanol and acetaldehyde and the morning-after consequences of acetaldehyde load -- the compound to look at is one that acts on the metabolic pathway, not on post-damage cleanup. DHM has been studied for the first, with mixed results in animal studies. Milk thistle, in the alcohol-specific literature, has not.
Supports overall liver health.†
† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
That is not the same as saying milk thistle is useless. It supports liver function in MASLD contexts where its antioxidant profile is the right tool for the job. It is just the wrong tool for what most consumers think they are buying it for.
What I Tested in My 150 Self-Tests
I included a milk thistle stack in my self-test rotation for about six weeks at 200mg silymarin per dose. It made no difference I could see against my no-supplement nights at that dose, which is consistent with the Cochrane finding that there is no demonstrated alcohol-specific effect. (this is the part where my personal data lined up cleanly with the published literature, which was a relief honestly.) I cut milk thistle from the formula candidates after that round.
For the enzyme research on DHM and how far it goes, see How DHM Works: The ADH/ALDH Pathway. For where our 1,500mg DHM dose came from, see DHM Dose-Response.